Recently, the FDA has approved the use of corneal crosslinking for the treatment of keratoconus in the U.S.A. In general, a B vitamin and UV light is used to stiffen the cornea of the keratoconic eye. The exact specifics are still evolving. The important point is that crosslinking doesn’t eliminate the keratoconus but it does stabilize it! Early diagnosis is more important now than ever. If progression can be halted, glasses may be used to improve vision in early stages. Contact lenses will improve vision in moderate stages, as well as in severe stages when extreme scarring is not present. It is hoped that corneal crosslinking will eventually eliminate the need for corneal transplant surgery in the treatment of keratoconus.
Posted In: Keratoconus